Lee A Hunt Clinical Oncology Society of Australia Annual Scientific Meeting 2020

Lee A Hunt

Lee was diagnosed with Grade 3 breast cancer in 2005. Following surgery, she undertook an 18-month therapy program but suffered a recurrence 13 years later. Following a 40-year career in education, she joined Cancer Voices and was invited by Sally Crossing to join the executive group, leading the Consumers Involved in Research program. Her work also includes submitting support documentation for MSAC applications, coordination of the MBS submissions and input into the updates of the Clinical guidelines - Cancer Council Australia. She has supported campaigns for radiation facilities at Dubbo Hospital and other regional locations. Lee is the consumer member of the Faculty of Radiation Oncology at RANZCR and the Media and Profile Committee involving support of Targeting Cancer activities. She supports various College committees by ensuring documents are 'consumers friendly' and reflect the ongoing needs of cancer patients. She is a member of the Radiation Oncology Roundtable that meets with the Department of Health. Cancer research is Lee's passion, with her being a member of several cancer research projects, including working with Professor Paul Keall at ACRF Image X Institute. Her co-authored publications include: Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews and Cancer Control in Chronic Care Nursing. Lee has presented at many conferences and other fora, including the COSA Survivorship conference, the Australian Society for Medical Research NSW, RANZCR's Annual Scientific Meeting and the National Particle Therapy Symposium. She has made presentations to early researchers at Cure Cancer, Sydney University and NSW Cancer Council.

Abstracts this author is presenting: